| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Active protection of mice against Salmonella typhi by immunization with strain-specific porins
|
Isibasi, Armando
|
|
1992
|
10 |
12 |
p. 811-813
3 p.
|
article
|
| 2 |
Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area
|
Wills, Mark R.
|
|
1992
|
10 |
12 |
p. 861-872
12 p.
|
article
|
| 3 |
Calendar
|
|
|
1992
|
10 |
12 |
p. 888-
1 p.
|
article
|
| 4 |
Comparison of immune responses to a native viral antigen and a synthetic peptide derived from it: implications for vaccine development
|
Kumar, Anil
|
|
1992
|
10 |
12 |
p. 814-816
3 p.
|
article
|
| 5 |
Hepatitis B virus vaccine containing new surface antigen; obtained by expression of recombinant surface antigen in Pichia pastoris which gives higher immunogenicity
|
|
|
1992
|
10 |
12 |
p. 886-887
2 p.
|
article
|
| 6 |
HIV virus gp120 alloepitope peptide and related molecules; useful as passive and active vaccine against AIDS, for immunotherapy and in vivo imaging and in screening of new anti-AIDS drugs
|
|
|
1992
|
10 |
12 |
p. 886-
1 p.
|
article
|
| 7 |
Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide-protein conjugate vaccine is decreased by admixture of high doses of free saccharide
|
Peeters, Carla C.A.M.
|
|
1992
|
10 |
12 |
p. 833-840
8 p.
|
article
|
| 8 |
Immunogenicity of inactivated purified tissue culture vaccine against hepatitis A (HepAvac) assessed in laboratory rodents
|
Elbert, L.B.
|
|
1992
|
10 |
12 |
p. 828-832
5 p.
|
article
|
| 9 |
Immunomodulatory action of propolis: IV. Prophylactic activity against Gram-negative infections and adjuvant effect of the water-soluble derivative
|
Dimov, Valentin
|
|
1992
|
10 |
12 |
p. 817-823
7 p.
|
article
|
| 10 |
Impaired response to hepatitis B vaccine in HIV infected children
|
Zuin, G.
|
|
1992
|
10 |
12 |
p. 857-860
4 p.
|
article
|
| 11 |
In vivo model for evaluation of species-specific virus vaccines
|
Skinner, G.R.B.
|
|
1992
|
10 |
12 |
p. 847-851
5 p.
|
article
|
| 12 |
Multiple promoter baculovirus expression system and defective particle production; nuclear-polyhedrosis virus vector for e.g. recombinant vaccine or diagnostic antigen production in insect cell culture
|
|
|
1992
|
10 |
12 |
p. 887-
1 p.
|
article
|
| 13 |
Nasal antibody response to mumps virus after vaccination and natural infection
|
Tanaka, Kazuko
|
|
1992
|
10 |
12 |
p. 824-827
4 p.
|
article
|
| 14 |
New mutant herpes simplex virus for use in vaccine e.g. HIV virus recombinant vaccine in attenuated vector
|
|
|
1992
|
10 |
12 |
p. 886-
1 p.
|
article
|
| 15 |
New T-cell epitope derived from the TraT protein of Escherichia coli; T-lymphocyte epitope useful as carrier in vaccine to enhance antibody production and stimulate strong cell-mediated immunity
|
|
|
1992
|
10 |
12 |
p. 887-
1 p.
|
article
|
| 16 |
Plasmodium liver stage antigen and cDNA encoding them; Plasmodium falciparum, Plasmodium vivax, Plasmodium berghei recombinant liver stage Pbl1 antigen and monoclonal antibody production; potential malaria vaccine
|
|
|
1992
|
10 |
12 |
p. 887-
1 p.
|
article
|
| 17 |
Readership survey
|
|
|
1992
|
10 |
12 |
p. 880-885
6 p.
|
article
|
| 18 |
Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells
|
Herrington, Deirdre A.
|
|
1992
|
10 |
12 |
p. 841-846
6 p.
|
article
|
| 19 |
Seroimmunity to poliomyelitis in an Albanian immigrant population
|
Squarcione, S.
|
|
1992
|
10 |
12 |
p. 853-856
4 p.
|
article
|
| 20 |
Specific and non-specific immunity and protection of macaques against SIV infection
|
Le Grand, Roger
|
|
1992
|
10 |
12 |
p. 873-879
7 p.
|
article
|
| 21 |
Vaccine against Actinobacillus pleuropneumoniae; fermentation comprising 92 kDa, 38 kDa outer membrane protein, outer and purification
|
|
|
1992
|
10 |
12 |
p. 886-
1 p.
|
article
|
| 22 |
Vaccine for combating Bordetella pertussis; new vaccine comprising 92 kDa, 38 kDa outer membrane protein, outer membrane vesicle, and pertussis toxin
|
|
|
1992
|
10 |
12 |
p. 886-
1 p.
|
article
|
Journal description